Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Merck-Eisai's Keytruda/Lenvima Combo Scores Japanese Approval For Kidney Cancer Setting
Tickers ESALF ESALY MRK
Tags ESALY Briefs News
From Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
Tickers ALKS AMGN ARGX BGNE
Tags Small Cap Biotech MRKR
From Benzinga
Merck Snags Yet Another Indication for This Drug Combo
Tickers ESALY MRK
Tags Recent Press Releases ESALY MRK
From Motley Fool
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
Tickers BIIB ESALF ESALY LLY
Tags ESALY Movers News
From Benzinga
Biogen Outlines Aduhelm's Confirmatory Trial Plans, Data Expected In 2026
Tickers BIIB ESALF ESALY
Tags Briefs News ESALY
From Benzinga
Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma
Tickers ESALF ESALY MRK
Tags Benzinga MRK ESALF
From Benzinga
Why Are Biogen Shares Gaining Today?
Tickers BIIB ESALF ESALY
Tags Market News Trading Ideas Benzinga
From Benzinga
Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial
Tickers BIIB ESALF ESALY
Tags General News Briefs
From Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
Tickers APTO APYX BIIB BLFS
Tags GILD MRK FDA
From Benzinga
3 Big Problems With Biogen's Q3 Results
Tickers BIIB ESALY SAGE
Tags ESALY Market News BIIB
From Motley Fool
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags ESALF General News
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
Tickers AFIB ALT AMZN APYX
Tags PSTI INCY ALT
From Benzinga
How Keytruda's Latest Approval in China Boosts Merck
Tickers ESALY MRK
Tags Market News MRK ESALY
From Motley Fool
Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential
Tickers CTXR ESALY RDY
Tags ESALY Price Target News
From Benzinga
Merck Investors Have Reason to Cheer This Label Expansion
Tickers ESALY MRK
Tags ESALY MRK Market News
From Motley Fool
Dr Reddy's To Sell Its Anti-Cancer Agent To Citius Pharma
Tickers ESALF ESALY RDY
Tags oncology Health Care Biotech
From Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Tickers ABSI AGEN ALKS AXNX
Tags News BNR RGEN
From Benzinga
Amid Medicare Uncertainty, Biogen Offers Its Alzheimer's Drug For Free
Tickers BIIB ESALF ESALY
Tags Benzinga Market News BIIB
From Benzinga
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
Tickers ADGI ASND BNR BNTX
Tags RNXT BNTX ELYM
From Benzinga
What This Label Expansion Means for Merck
Tickers ESALY MRK PFE
Tags PFE MRK ESALY
From Motley Fool
White House Dismisses Janet Woodcock As Permanent FDA Commissioner Candidate: Bloomberg
Tickers BIIB ESALF ESALY
Tags COVID/19 Vaccine ESALF General
From Benzinga
Controversial Aduhelm To Administered At More Than 300 Hospitals: Nikkei's
Tickers BIIB ESALF ESALY
Tags Biotech Health Care BIIB
From Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Tickers ABSI AXSM BIOC BNTX
Tags FATE ETON FDA
From Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Tickers ABCL ACET ACHV ADGI
Tags MNOV MCRB ELDN
From Benzinga
Biogen's New Alzheimer's Drug Turned Away By Veterans Affairs
Tickers BIIB ESALF ESALY
Tags ESALF ESALY News
From Benzinga
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
Tickers ALBO AXSM CARA CCXI
Tags News PRVB ESALY
From Benzinga
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
Tickers ABBV ABSI ACET ALKS
Tags SOPH RXST MSON
From Benzinga
Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients
Tickers BIIB ESALF ESALY
Tags ESALF ESALY News
From Benzinga
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
Tickers ABT ARVN AVTE BHVN
Tags Penny Stocks LUMO Benzinga
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Review Could Have Been Handled Differently, Says FDA Chief: STAT News
Tickers BIIB ESALF ESALY
Tags ESALF Briefs News
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.